Personalis — cancer genomics (MRD testing)
Sector: health
Conviction from: NASDAQCitrini
52-week range: 4.9618.89
4 tracked filer(s) hold this · 3 opened, 0 added, 0 trimmed in 30-SEP-2026
Aggregate 13FScore 50 — mean of 4 scored holder(s) · buyers (new/add) avg 53. Higher = the smart money in this name has the better track record.
| Filer | 13FScore | This quarter | Shares | Value | % of their book |
|---|
| Steve Cohen / Point72 | 75 | New buy | 126,427 | $2,058,232 | 0.0% |
| George Soros / Soros Fund Mgmt | 33 | New buy | 250,000 | $4,070,000 | 0.0% |
| Louis Bacon / Moore | 52 | New buy | 110,000 | $1,790,800 | 0.0% |
| Ancora | 42 | Holds (flat) | 690 | $11,233 | 0.0% |
Beyond 13F — activists, insiders, politicians & research
| Filed | Insider | Role | Shares | Value | |
|---|
| 2026-02-13 | Tempus AI, Inc. | 10%-owner | 320,267 | $2,739,181 | Form 4 |
| Report | Date | Stance |
|---|
| #80 — Market Memo: January Musings | 2025-01-09 | LONG |